This is a prospective , randomised trial evaluating the effects of either intensive glucose control ( target glucose 80-120 mg/dl ) or conventional control ( target glucose 180 mg/dl or less ) with insulin on platelet reactivity in patients with ACS and hyperglycaemia .
